Potential new medications for Parkinson’s cognitive decline With Parkinson’s disease (PD), cognitive issues are quite common. Yet, there are...see more currently few medications available to help alleviate this troubling symptom. In the recent past, there were a scarcity of clinical trials testing potential medications for cognitive difficulties and PD. Currently, there is now a long list […]

Read More

APDA-funded Parkinson’s Research Successes: 2022 Update Since 1961, APDA has been a funding partner in many major scientific breakthroughs...see more and has awarded nearly $55 million in Parkinson’s disease (PD) research grants to date. APDA funds individual research grants and fellowships to scientists performing innovative PD research.

Read More

Currently, Parkinson’s disease (PD) diagnosis is based on a visual clinical exam, done by a doctor (ideally a neurologist...see more or movement disorder specialist) in their office. This means that motor symptoms such as tremor, stiffness and slowness must be apparent before a diagnosis is made by the neurologist – yet those visible symptoms don’t often […]

Read More

  Every year the International Parkinson and Movement Disorder Society (MDS) holds a conference and every year APDA is...see more there, learning about the newest research and sharing our resources with the wider Parkinson’s disease (PD) community. The MDS Congress is the preeminent gathering of medical professionals from around the world who are dedicated to PD […]

Read More

NEW, INNOVATIVE PARKINSON’S DISEASE RESEARCH BEING FUNDED BY APDA On September 1, 2021, APDA announced our research grantees for...see more the year ahead. Our grant recipients are working tirelessly to understand the complexities of Parkinson’s disease in an effort to develop new treatments and eventually, a cure, and we are honored to support their work. This […]

Read More

Learn more about how Parkinson’s research grant proposals are created, from inception to submission to APDA Every May, APDA’s...see more Scientific Advisory Board  (SAB) meets to choose the research grants that APDA will fund in the upcoming fiscal year. APDA’s SAB is comprised of highly successful scientists with a broad range of backgrounds and expertise in […]

Read More

Meet Dr. April Darling, an APDA-funded researcher studying methods to reduce alpha-synuclein in the brains of people with Parkinson’s...see more disease. Our A Closer Look blog is designed to educate, inform, and inspire you through a variety of topics and insights about Parkinson’s disease (PD). One way we do that is through our Interview with APDA Researchers series, as a […]

Read More

The year 2021 marks the 60th Anniversary of APDA, which was founded in 1961. This milestone has given us...see more the chance to look back at our accomplishments over the past 60 years and reflect on what we have achieved – and also what we have yet to achieve. One of the key pillars of APDA’s mission […]

Read More

The Latest in Parkinson’s Research from AAN 2021 The American Academy of Neurology (AAN) is the preeminent professional association...see more for neurologists in the US dedicated to supporting and improving the profession of neurology. Every year, AAN holds an annual conference at which new data on all aspects of neurology, including Parkinson’s disease (PD), is presented. […]

Read More